Concepedia

LI Liu

LL

Statistics

Publications

2

Citations

20

H-Index

2

Active since

2023

Affiliations

Army Medical University(Current)

LI Liu is an author at Army Medical University specializing in dual-target car t cells, immunotherapy, and chimeric antigen receptor t cell combination therapy.

Publications per year

2023–2023

2

Publications

2

First-in-human phase 1 dose escalation study of the KAT6 inhibitor PF-07248144 in patients with advanced solid tumors.

David Sommerhalder, Erika Hamilton, Toru Mukohara et al. · Journal of Clinical Oncology · 2023 · 10 citations

, , +14

P869: UPDATED RESULTS OF A PHASE I, OPEN-LABEL STUDY OF BCMA/CD19 DUAL-TARGETING FASTCAR-T GC012F FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)

Juan Du, Weijun Fu, Hua Jiang et al. · HemaSphere · 2023 · 10 citations · Full text

, , +17

1–2 of 2